Search - tctmd.com

Displaying 181 - 200 of 253

Sort: Relevancy | Date

News Conference News ACC 2017

Live From Washington: ACC 2017, Day One

Shelley Wood

March 17, 2017

News Daily News

TAVR Boosts Health Status in Most Patients, but Many Still Suffer Postprocedure

Todd Neale

February 06, 2017

News Conference News TCT 2016

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

Todd Neale

November 02, 2016

News Industry News TCT 2016

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

November 01, 2016

Presentation TCT 2016

TCT 810: Percutaneous Mitral Valve Repair for Management of Systolic Anterior Motion and Mitral Regurgitation Associated with Hypertrophic Cardiomyopathy

Presenter: Brij Maini, James E. Muller

October 31, 2016

Presentation TCT 2016

Severe AS and Hypertrophic Cardiomyopathy

Presenter: Jean-Claude Laborde, Wilson Y. Szeto, Paul Sorajja

October 31, 2016

News Daily News

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

L.A. McKeown

August 24, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Daily News

Patients With Low Aortic Valve Gradient May Be Less Likely to Reap TAVR’s Benefits

Todd Neale

May 16, 2016

News Industry News

MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy

October 07, 2015

Presentation TCT 2014

TCT 64: Coil Embolization for Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: Long-term Results

Presenter: Igor F. Palacios, Augusto D. Pichard, Kishore J. Harjai, Israel Guerrero Mantilla, MD

September 16, 2014

Presentation TCT 2014

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Presenter: Igor F. Palacios, Augusto D. Pichard, Kishore J. Harjai, Malek Al-Hawwas, MD

September 16, 2014

Presentation TCT 2014

Interventional Perspective: Not Surgery of Course!

Presenter: Carey D. Kimmelstiel

September 16, 2014

Presentation TCT 2014

Surgeon's Perspective on HOCM surgery

Presenter: John D. Puskas

September 16, 2014

Presentation TCT 2014

Long-term Outcomes Following Alcohol Septal Ablation: Is the Procedure Durable?

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

Complications of Alcohol Septal Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

Patient Management Post Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

HCM Ablation Step-by-Step and Avoiding Potential Pitfalls

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh, Valerian Fernandes

September 16, 2014

Presentation TCT 2014

Case Selection and Use of Myocardial Contrast Echocardiography During Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

When to Consider Septal Reduction Therapy

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann

September 16, 2014

Advertisement

Live From Washington: ACC 2017, Day One

TAVR Boosts Health Status in Most Patients, but Many Still Suffer Postprocedure

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

TCT 810: Percutaneous Mitral Valve Repair for Management of Systolic Anterior Motion and Mitral Regurgitation Associated with Hypertrophic Cardiomyopathy

Severe AS and Hypertrophic Cardiomyopathy

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Patients With Low Aortic Valve Gradient May Be Less Likely to Reap TAVR’s Benefits

MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy

TCT 64: Coil Embolization for Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: Long-term Results

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Interventional Perspective: Not Surgery of Course!

Surgeon's Perspective on HOCM surgery

Long-term Outcomes Following Alcohol Septal Ablation: Is the Procedure Durable?

Complications of Alcohol Septal Ablation

Patient Management Post Ablation

HCM Ablation Step-by-Step and Avoiding Potential Pitfalls

Case Selection and Use of Myocardial Contrast Echocardiography During Ablation

When to Consider Septal Reduction Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content